Shirayama Takeshi
Kyoto Prefectural University of Medicine, Department of Medicine, Division of Cardiology, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Indian Pacing Electrophysiol J. 2003 Oct 1;3(4):224-30.
Atrial fibrillation could be induced reproducibly by 50 Hz rapid stimulation which was given through systolic and early diastolic phase of atrial excitation. Duration of atrial fibrillation induced in this way was roughly dependent on the current amplitude of the stimulation. The minimum current that could induce long-lasting atrial fibrillation (30 sec in the clinical setting, 2 sec in the rabbit or rat model) was defined as atrial fibrillation threshold (AFT). AFT was larger in patients who had history of atrial fibrillation than those who did not. Anti-arrhythmic drugs raised AFT by various degrees both in experimental and clinical cases. Long-term efficacy of a drug could be predicted in a patient, measuring how much the drug increased AFT (cut-off point = 5 mA increase). AFT is a useful marker to evaluate atrial vulnerability and to guide pharmacological treatment of atrial fibrillation.
通过在心房兴奋的收缩期和舒张早期给予50Hz快速刺激,可重复性地诱发心房颤动。以这种方式诱发的心房颤动持续时间大致取决于刺激的电流幅度。能够诱发持久心房颤动的最小电流(临床环境中为30秒,兔或大鼠模型中为2秒)被定义为心房颤动阈值(AFT)。有房颤病史的患者的AFT高于无房颤病史的患者。在实验和临床病例中,抗心律失常药物均不同程度地提高了AFT。通过测量药物使AFT升高的幅度(临界点=升高5mA),可以预测患者对药物的长期疗效。AFT是评估心房易损性和指导房颤药物治疗的有用指标。